Regulators cite contract deficiencies as some companies challenge the findings
TALLAHASSEE, Florida
Florida announced more than $12.66 million in pharmacy benefit manager penalties on November 9, according to the Office of Insurance Regulation (OIR).
The findings concern pricing, pharmacy access, payments and unilateral contract changes. OIR said some companies are correcting deficiencies while others challenge findings or penalties through litigation.
Capital Rx disputed nearly all eight findings in its examination, Insurance Journal reported November 17. On pharmacy access, the company maintained that its contracts already contained equivalent language.
The enforcement actions concern Florida, not Puerto Rico.


